The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity

Michael G. Sarr,Charles J. Billington, Roy Brancatisano,Anthony Brancatisano,James Toouli, Lilian Kow,Ninh T. Nguyen,Robin Blackstone,James W. Maher,Scott Shikora, Dominic N. Reeds,J. Christopher Eagon,Bruce M. Wolfe,Robert W. O’Rourke,Ken Fujioka,Mark Takata,James M. Swain,John M. Morton,Sayeed Ikramuddin, Michael Schweitzer,Bipan Chand,Raul Rosenthal, The EMPOWER Study Group

Obesity Surgery（2012）

引用 154|浏览8

暂无评分

摘要

Intermittent, reversible intraabdominal vagal blockade (VBLOC® Therapy) demonstrated clinically important weight loss in feasibility trials. EMPOWER, a randomized, double-blind, prospective, controlled trial was conducted in USA and Australia.

查看译文

关键词

Morbid obesity,Vagal modulation,Vagal blockade,Neuromodulation,Weight loss,Satiety,Blood pressure

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要